Analyst: Amazon Possibly Priming Itself As Medical Device Retailer

The online retail giant has long been considered a potential threat to retail and mail-order pharmacists but, according to at least one analyst, the company may actually be gearing up to home-deliver medical devices to several states.

Las Vegas - Circa July 2017: Amazon.com Fulfillment Center. Amazon is the Largest Internet-Based Retailer in the United States II
Amazon fulfillment center in Las Vegas • Source: Jonathan Weiss/Shutterstock

For months market analysts have been discussing [Amazon.com Inc.]'s potential foray as a mail-order pharmacy, but after recent reports detailed the company's regulatory efforts at least one analyst says the real deal may be that the it is showing signs of trying to conquer the medical device supply sector.

Last week, the St. Louis Post-Dispatch reported that, over the past year, the online retail giant has gained...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Strategy

More from Business

Novel Pathway For Combined Drug/IVD Trials Wins Backing Of EU Nations

 
• By 

Broad participation by EU member states in a new pilot to test a unified procedure for evaluating applications for combined drug and IVD studies shows they recognize its value, says Monique Al, vice-chair of the Clinical Trials Coordination Group.

‘Be Quick, But Don’t Hurry’: Dexcom CEO Talks CGM Market Success

 
• By 

Dexcom’s CEO Kevin Sayer discusses this fall’s planned launch of the 15-day G7 CGM, downplays Abbott’s dual-sensor while focusing on development of multi-analyte G8, making OTC Stelo app more “consumerish” for Europeans, and more.

Medtronic’s ‘Strategic Expansion’ Into Remote Monitoring

 

“The Corsano wearable strengthens Medtronic’s acute care and monitoring portfolio,” Marc De Martini, vice president at Medtronic, told Medtech Insight.